Testing potential developmental toxicants with a cytotoxicity assay based on human embryonic stem cells

Alternatives to Laboratory Animals

Volumn 36, Issue 2, 2008, Pages 129-140

  Adler, Sarah ^a   Lindqvist, Jenny ^a   Uddenberg, Katarina ^a   Hyllner, Johan ^a   Strehl, Raimund ^a  

^a Cellartis AB   (Sweden)

Author keywords

Alternative methods; Cytotoxicity; Embryotoxicity; Human embryonic stem cells; Inter species differences; Retinoids

Indexed keywords

ADENOSINE TRIPHOSPHATE; BASIC FIBROBLAST GROWTH FACTOR; DIMETHYL SULFOXIDE; FLUOROURACIL; ISOTRETINOIN; RESAZURIN; RETINOIC ACID; SACCHARIN; VALPROIC ACID;

ANIMAL CELL; ARTICLE; CELL ASSAY; CELL MATURATION; CELL TYPE; CELL VIABILITY; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOTOXICITY; EMBRYONIC STEM CELL; EMBRYOTOXICITY; FIBROBLAST; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; STEM CELL;

MURINAE;

EID: 45549093674     PISSN: 02611929     EISSN: None     Source Type: Journal    
DOI: 10.1177/026119290803600204     Document Type: Article

References (31)

1. Gilbert, S.F. (2003). Developmental Biology, 750pp. Sunderland, MA, USA: Sinauer Associates, Inc.
2. Nau, H. (2001). Teratogenicity of isotretinoin revisited: species variation and the role of all-trans-retinoic acid. Journal of the American Academy of Dermatology 45, S183-187.
3. Genschow, E., Spielmann, H., Scholz, G., Pohl, I., Seiler, A., Clemann, N., Bremer, S. & Becker, K. (2004). Validation of the embryonic stem cell test in the international ECVAM validation study on three in vitro embryotoxicity tests. ATLA 32, 209-244.
4. Hurtt, M.E., Cappon, G.D. & Browning, A. (2003). Proposal for a tiered approach to developmental toxicity testing for veterinary pharmaceutical products for food-producing animals. Food & Chemical Toxicology 41, 611-619.
5. Mao, Y. & Lee, A.W. (2005). A novel role for Gab2 in bFGF-mediated cell survival during retinoic acidinduced neuronal differentiation. The Journal of Cell Biology 170, 305-316.
6. Miho, Y., Kouroku, Y., Fujita, E., Mukasa, T., Urase, K., Kasahara, T., Isoai, A., Momoi, M.Y. & Momoi, T. (1999). bFGF inhibits the activation of caspase-3 and apoptosis of P19 embryonal carcinoma cells during neuronal differentiation. Cell Death & Differentiation 6, 463-470.
7. Anon. (1987). Teratology Society position paper: recommendations for Vitamin A use during pregnancy. Teratology 2, 269-275.
8. Hendrickx, A.G. (1998). Teratogenicity of retinoids in rodents, primates and humans. The Journal of Toxicological Sciences 23, 272.
9. Anon. (2000). Scientific Frontiers in Developmental Toxicology and Risk Assessment, 354pp. Washington, DC, USA: National Academy Press.
10. De Sesso, J.M., Scialli, A.R. & Goeringer, G.L. (1995). Observations on the histopathogenesis of 5-fluorouracil developmental toxicity in New Zealand white rabbits and its amelioration by TTI, a functional analog of one carbon metabolism. Teratology 51, 172.
11. Stephens, J.D., Golbus, M.S., Miller, T.R., Wilber, R.R. & Epstein, C.J. (1980). Multiple congenital anomalies in a fetus exposed to 5-fluorouracil during the first trimester. American Journal of Obstetrics & Gynecology 137, 747-749.
12. Jacob, S.W. & Herschler, R. (1986). Pharmacology of DMSO. Cryobiology 23, 14-27.
13. Adler, S., Pellizzer, C., Paparella, M., Hartung, T. & Bremer, S. (2006). The effects of solvents on embryonic stem cell differentiation. Toxicology in Vitro 20, 265-271.
14. Brown, N.A. (2002). Selection of test chemicals for the ECVAM international validation study on in vitro embryotoxicity tests. ATLA 30, 177-198.
15. Dagg, C.P. (1960). Sensitive stages for the production of developmental abnormalities in mice with 5-fluorouracil. American Journal of Anatomy 106, 89-96.
16. Anon. (1997). Notice of Filing of Pesticide Petitions. US Environmental Protection Agency (EPA). Federal Register 62, 34,261-34,271.
17. Newman, L.M., Johnson, E.M. & Staples, R.E. (1993). Assessment of the effectiveness of animal developmental toxicity testing for human safety. Reproductive Toxicology 7, 359-390.
18. Evans, S.M., Casartelli, A., Herreros, E., Minnick, D.T., Day, C., George, E. & Westmoreland, C. (2001). Development of a high throughput in vitro toxicityscreen predictive of high acute in vivo toxic potential. Toxicology in Vitro 15, 579-584.
19. Laschinski, G., Vogel, R. & Spielmann, H. (1991). Cytotoxicity test using blastocyst-derived euploid embryonal stem cells: a new approach to in vitro teratogenesis screening. Reproductive Toxicology 5, 57-64.
20. Adler, S., Paparella, M., Pellizzer, C., Hartung, T. & Bremer, S. (2005). The detection of differentiation-inducing chemicals by using green fluorescent protein expression in genetically engineered terato-carcinoma cells. ATLA 33, 91-103.
21. Schroeder, M. & Zouboulis, C.C. (2007). All-trans-retinoic acid and 13-cis-retinoic acid: Pharmacokinetics and biological activity in different cell culture models of human keratinocytes. Hormone & Metabolic Research 39, 136-140.
22. Spinella, M.J., Kerley, J.S., White, K.A. & Curtin, J.C. (2003). Retinoid target gene activation during induced tumor cell differentiation: human embryonal carcinoma as a model. The Journal of Nutrition 133, 273S-276S.
23. Simoni, D. & Tolomeo, M. (2001). Retinoids, apoptosis and cancer. Current Pharmaceutical Design 7, 1823-1837.
24. Nelson, A.M., Gilliland, K.L., Cong, Z. & Thiboutot, D.M. (2006). 13-cis-retinoic acid induces apoptosis and cell cycle arrest in human SEB-1 sebocytes. The Journal of Investigative Dermatology 126, 2178-2189.
25. Mangelsdorf, D.J. (1994). Vitamin A receptors. Nutrition Reviews 52, S32-S44.
26. Aström, A., Pettersson, U., Krust, A., Chambon, P. & Vorhees, J.J. (1990). Retinoic acid and synthetic analogs differentially activate retinoic acid receptor dependent transcription. Biochemical & Biophysical Research Communications 173, 339-345.
27. Tsukada, M., Schröder, M., Roos, T.C., Chandraratna, R.A., Reichert, U., Merk, H.F., Orfanos, C.E. & Zouboulis, C.C. (2000). 13-cis retinoic acid exerts its specific activity on human sebocytes through selective intracellular isomerization to all-trans retinoic acid and binding to retinoid acid receptors. The Journal of Investigative Dermatology 115, 321-327.
28. Wiltse, J. (2005). Mode of action: inhibition of histone deacetylase, altering Wnt-dependent gene expression, and regulation of beta-catenin- developmental effects of valproic acid. Critical Reviews in Toxicology 35, 727-738.
29. Maring, J.G., Groen, H.J. & Wachters, F.M. (2005). Genetic factors influencing pyrimidine-antagonist chemotherapy. The Pharmacogenomics Journal 5, 226-243.
30. Bremer, S. & Hartung, T. (2004). The use of embryonic stem cells for regulatory developmental toxicity testing in vitro - the current status of test development. Current Pharmaceutical Design 10, 2733-2747.
31. Cho, Y.M., Kwon, S., Pak, Y.K., Seol, H.W., Choi, Y.M., Park, D.J., Park, K.S. & Lee, H.K. (2006). Dynamic changes in mitochondrial biogenesis and antioxidant enzymes during the spontaneous differentiation of human embryonic stem cells. Biochemical & Biophysical Research Communications 348, 1472-1478.